机译:突变蛋白作为癌症特异性生物标志物
Ludwig Center for Cancer Genetics and Therapeutics,Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231,The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231;
McKusick-Nathans Institute of Genetic Medicine,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,lnstitute of Bioinf ormatics, Bangalore 560066, India;
Ludwig Center for Cancer Genetics and Therapeutics,Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231,The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231;
Ludwig Center for Cancer Genetics and Therapeutics,Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231,The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231;
Ludwig Center for Cancer Genetics and Therapeutics,Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231,The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231;
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892;
The Sol Goldman Pancreatic Cancer Research Center,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,Departments of Pathology,Johns Hopkins Medical Institutions, Baltimore, MD, 21205;
The Sol Goldman Pancreatic Cancer Research Center,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,Departments of Pathology,Johns Hopkins Medical Institutions, Baltimore, MD, 21205;
The Sol Goldman Pancreatic Cancer Research Center,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,Departments of Pathology,Johns Hopkins Medical Institutions, Baltimore, MD, 21205;
The Sol Goldman Pancreatic Cancer Research Center,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,Departments of Pathology,Johns Hopkins Medical Institutions, Baltimore, MD, 21205;
Ludwig Center for Cancer Genetics and Therapeutics,Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231,The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231;
McKusick-Nathans Institute of Genetic Medicine,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,The Sol Goldman Pancreatic Cancer Research Center,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,Departments of Pathology,Johns Hopkins Medical Institutions, Baltimore, MD, 21205,Departments of Biological Chemistry,Johns Hopkins Medical Institutions, Baltimore, MD, 21205;
Ludwig Center for Cancer Genetics and Therapeutics,Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231,The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231;
genetics; proteomics; pancreatic cancer; genetic diagnosis; companion diagnostics;
机译:结构和功能表征解释了癌症特异性R366C / H突变体SamHD1蛋白的DNTPase活性的丧失
机译:膀胱癌特异性核基质蛋白-4可以是用于非肌肉侵入性膀胱癌检测的潜在生物标志物
机译:DNA甲基化和基因表达的整合分析鉴定了宫颈癌特异性诊断生物标志物
机译:EGFR-相互作用蛋白的蛋白质组学分析,以阐明肺癌特异性突变蛋白的信号转导差异
机译:基于结构的突变蛋白设计:I.氨基酸与野生型氨酰基tRNA合成酶结合的分子对接研究。二。非天然氨基酸掺入的突变型氨酰基-tRNA合成酶的基于结构的设计。
机译:突变蛋白作为癌症特异性生物标志物
机译:突变蛋白作为癌症特异性生物标志物